SHENZHEN, China, Nov. 21, 2022 /PRNewswire/ -- BGI Group signed three Memorandum of Understandings (MOUs) in the lead up to the G20 Summit in Bali with the Indonesian Ministry of Health, the University of Indonesia and the Del Institute of Technology (Institut Teknologi Del). The MOUs cover genomics development initiatives, construction of related laboratories, and joint research and personnel training.
The signings were witnessed by Coordinating Minister of Maritime and Investment Affairs of Indonesia, Luhut Binsar Pandjaitan, Indonesian Minister of Health, Budi Gunadi Sadikin, and Chairman and Co-Founder of BGI Group, Wang Jian.
Wang Jian also spoke during the "Tri Hita Karana (THK) Future Knowledge Summit" in Bali, an official side event of the G20 Summit, where he delivered a speech on the development of cutting-edge technologies such as single-cell sequencing and spatiotemporal omics, and their impact on precision medicine, public health, and next-generation agricultural tools.
Genomics was announced as an integral part of the Indonesian Ministry of Health's medical transformation strategy. On August 14th 2022, Indonesia established its first national integrated biomedical programme, the "Biomedical and Genome Science Initiative" (BGSi). MGI Tech Co., Ltd., an affiliate of BGI Group is one of the designated sequencing platform partners for the initiative.
BGI Group, a pioneer in life sciences, is one of the world's leading biotechnology organizations with operations covering research, production, and applications in more than 100 countries and regions. BGI Group's work includes ground-breaking science discoveries, innovative research into microbiology and biodiversity, diagnostic testing services to trace viruses and diseases, the development of next generation technologies for large-scale gene sequencing, and the novel spatialomics technology Stereo-seq. BGI placed 1st in Asia Pacific and 8th globally amongst corporates for high-quality scientific research papers in life sciences in the 2022 Nature Index.
